These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15608458)

  • 1. Prevention of graft rejection by donor type II CD8(+) T cells (Tc2 cells) is not sufficient to improve engraftment in fetal transplantation.
    Chen JC; Chang ML; Lee H; Muench MO
    Fetal Diagn Ther; 2005; 20(1):35-43. PubMed ID: 15608458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploidentical donor T cells fail to facilitate engraftment but lessen the immune response of host T cells in murine fetal transplantation.
    Chen JC; Chang ML; Lee H; Muench MO
    Br J Haematol; 2004 Aug; 126(3):377-84. PubMed ID: 15257710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-host-reactive donor CD8+ T cells of Tc2 phenotype potently inhibit marrow graft rejection.
    Fowler DH; Whitfield B; Livingston M; Chrobak P; Gress RE
    Blood; 1998 Jun; 91(11):4045-50. PubMed ID: 9596648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice.
    Bhattacharyya S; Chawla A; Smith K; Zhou Y; Talib S; Wardwell B; Cowan MJ
    J Immunol; 2002 Dec; 169(11):6133-40. PubMed ID: 12444116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In utero engraftment of fully H-2-incompatible versus congenic adult bone marrow transferred into nonanemic or anemic murine fetal recipients.
    Howson-Jan K; Matloub YH; Vallera DA; Blazar BR
    Transplantation; 1993 Sep; 56(3):709-16. PubMed ID: 8212171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H; LeGuern C; Sachs DH; Sykes M
    Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
    J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of allografts in the peritoneal cavity after prenatal transplantation in mice.
    Chen JC; Chang ML; Muench MO
    Transfusion; 2008 Mar; 48(3):553-60. PubMed ID: 18067493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
    Bhattacharyya S; Cowan MJ
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
    Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infusion of Lin- bone marrow cells results in multilineage macrochimerism and skin allograft tolerance in minimally conditioned recipient mice.
    Anam K; Amare MF; Zins SR; Davis TA
    Transpl Immunol; 2010 Oct; 24(1):69-75. PubMed ID: 20950686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-stimulated/Tc2 cells abrogate murine marrow graft rejection.
    Erdmann AA; Jung U; Foley JE; Toda Y; Fowler DH
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):604-13. PubMed ID: 15319772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantation.
    Kutsuna N; Yamazaki S; Kaiga T; Inagaki Y; Hayashi Y; Kanamoto A; Okada S; Takayama T
    J Surg Res; 2012 Nov; 178(1):133-8. PubMed ID: 22502904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microchimerism and tolerance after in utero bone marrow transplantation in mice.
    Kim HB; Shaaban AF; Yang EY; Liechty KW; Flake AW
    J Surg Res; 1998 Jun; 77(1):1-5. PubMed ID: 9698523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
    Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL
    Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.